 |
|
| | A drug used to treat certain types of chronic myeloid leukemia and acute lymphoblastic leukemia. BMS-354825 is also being studied in the treatment of certain other blood diseases and types of cancer. BMS-354825 binds to and blocks BCR-ABL and other proteins that help cancer cells grow. It is a type of tyrosine kinase inhibitor. Also called dasatinib and Sprycel. |
| Previous Definitions: | BMS-184476, BMS-188797, BMS-214662, BMS-247550, BMS-275291 | | Next Definitions: | BMS-599626, body image, body mass index, bolus, bolus infusion |
|
|
